Kevin Fischbeck
Stock Analyst at B of A Securities
(4.05)
# 591
Out of 4,735 analysts
160
Total ratings
66.09%
Success rate
6.17%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgrades: Neutral | $247 → $308 | $284.67 | +8.20% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $14.21 | +33.71% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $524.99 | +23.81% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $27.10 | +77.12% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $3.41 | -12.02% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $169.97 | -14.69% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $389.22 | +36.17% | 3 | Jul 18, 2024 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $105 → $90 | $44.37 | +102.84% | 5 | May 2, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $297.44 | +47.59% | 15 | Apr 1, 2024 | |
| AHCO AdaptHealth | Downgrades: Underperform | $6.5 | $10.50 | -38.10% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $14.57 | -50.24% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $63.66 | +13.10% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $288.59 | +21.28% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $188.78 | -3.06% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $20.47 | +119.83% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $95.79 | -22.75% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $294 → $323 | $318.47 | +1.42% | 8 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.30 | +66.67% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $19.33 | +81.07% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $4.24 | +135.85% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $134.43 | -62.81% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $18.21 | -58.81% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $29.47 | -38.92% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.00 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $52.75 | -63.98% | 2 | Feb 9, 2018 |
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $284.67
Upside: +8.20%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $14.21
Upside: +33.71%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $524.99
Upside: +23.81%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $27.10
Upside: +77.12%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $3.41
Upside: -12.02%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $169.97
Upside: -14.69%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $389.22
Upside: +36.17%
Acadia Healthcare Company
May 2, 2024
Maintains: Buy
Price Target: $105 → $90
Current: $44.37
Upside: +102.84%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $297.44
Upside: +47.59%
AdaptHealth
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $10.50
Upside: -38.10%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $14.57
Upside: -50.24%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $63.66
Upside: +13.10%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $288.59
Upside: +21.28%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $188.78
Upside: -3.06%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $20.47
Upside: +119.83%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $95.79
Upside: -22.75%
Apr 24, 2023
Maintains: Buy
Price Target: $294 → $323
Current: $318.47
Upside: +1.42%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.30
Upside: +66.67%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $19.33
Upside: +81.07%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $4.24
Upside: +135.85%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $134.43
Upside: -62.81%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $18.21
Upside: -58.81%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $29.47
Upside: -38.92%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.00
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $52.75
Upside: -63.98%